ScoreComparison
Why is Fuji Pharma Co., Ltd. ?
1
Weak Long Term Fundamental Strength with a 6.62% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Net Sales has grown by an annual rate of 7.08% and Operating profit at 6.62% over the last 5 years
- DEBT-EQUITY RATIO (HY) Lowest at 54.2 %
- RAW MATERIAL COST(Y) Fallen by -6.26% (YoY)
- DEBTORS TURNOVER RATIO(HY) Highest at 2.85%
3
With ROCE of 7.08%, it has a very attractive valuation with a 0.80 Enterprise value to Capital Employed
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 53.49%, its profits have fallen by -27.9%
4
Market Beating performance in long term as well as near term
- Along with generating 53.49% returns in the last 1 year, the stock has outperformed Japan Nikkei 225 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Fuji Pharma Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Fuji Pharma Co., Ltd. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Fuji Pharma Co., Ltd.
53.49%
1.58
29.13%
Japan Nikkei 225
38.59%
1.45
26.59%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.08%
EBIT Growth (5y)
6.62%
EBIT to Interest (avg)
45.26
Debt to EBITDA (avg)
2.68
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
0.65
Tax Ratio
20.55%
Dividend Payout Ratio
34.57%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.78%
ROE (avg)
8.22%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.70
EV to EBIT
11.27
EV to EBITDA
6.14
EV to Capital Employed
0.80
EV to Sales
1.09
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.08%
ROE (Latest)
7.95%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at 54.2 %
RAW MATERIAL COST(Y)
Fallen by -6.26% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 2.85%
-22What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.38%
INTEREST(Q)
At JPY 95 MM has Grown at 43.94%
INTEREST COVERAGE RATIO(Q)
Lowest at 2,133.68
NET PROFIT(Q)
At JPY 539.56 MM has Fallen at -41.42%
Here's what is working for Fuji Pharma Co., Ltd.
Debt-Equity Ratio
Lowest at 54.2 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 2.85%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -6.26% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Fuji Pharma Co., Ltd.
Interest
At JPY 95 MM has Grown at 43.94%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Interest Coverage Ratio
Lowest at 2,133.68
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Inventory Turnover Ratio
Lowest at 1.38% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Interest
Highest at JPY 95 MM
in the last five periods and Increased by 43.94% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Net Profit
Lowest at JPY 539.56 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
Net Profit
At JPY 539.56 MM has Fallen at -41.42%
over average net sales of the previous four periods of JPY 921.06 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
